Recent Updates
Recently added Catalysts
LLY

Lilly To Present At Leerink Partners Global Healthcare Conference Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, 2018. Jan Lundberg,...

Key Takeaway: INDIANAPOLIS , Jan. 26, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, 2018 . Jan Lundberg , Ph.D., executive vice president for science and technology and president of Lilly Rese

Full Press Release Details

INDIANAPOLIS , Jan. 26, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 15, 2018 . Jan Lundberg , Ph.D., executive vice president for science and technology and president of Lilly Research Laboratories, and Dan Skovronsky , M.D., Ph.D., senior vice president of clinical and product development at Lilly, will participate in a fireside chat at 10:30 a.m., Eastern Time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at http://investor.lilly.com/events.cfm . A replay of the fireside chat will be available for approximately 90 days.
About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels . F-LLY
Lauren Zierke ; [email protected] ; (317) 277-6524 (Media) Phil Johnson ; [email protected] ; (317) 655-6874 (Investors)
SOURCE Eli Lilly and Company

Related Links

21 %

Last updated: Jan 26, 2018